LARGE1 and proximal spinal muscular atrophy: Combined results of our study unveil LARGE1 as a novel fluid biomarker in 5q-realted SMA: we demonstrate that LARGE1 is increased in CSF derived from pediatric patients suffering from SMA irrespective of the clinical subtype of the disease but not in CSF derived from children suffering from inflammatory or non-inflammatory CNS diseases.